The findings, generated using patient-derived stem cells and advanced brain models, could support the development of targeted therapies for Huntington’s disease, which progressively damages movement, cognitive function and behavioural control.
The country has also discharged its last Ebola patient and entered the 42-day countdown required to declare the outbreak over.
The accreditation covers Fakeeh Health, including FUH and its network of Fakeeh Medical Centers, and recognizes the organization as an approved institution for PGME training in the UAE.
The proposed Biotech Life Sciences Park will undergo a feasibility study after APIFA Biotech’s privately initiated proposal received approval to advance to the project development stage under a public-private partnership (PPP) arrangement.
Aster DM Healthcare was represented by Rahul Kadavakolu, Group Chief Marketing Officer, while Boehringer Ingelheim was represented by Ousama Alhaj, General Manager and Head of Human Pharma for the Near East and UAE, alongside Ghaleb Al Ahdab, Head of Public and Government Affairs for the Near East and UAE.
The partnership brings together PureHealth’s expertise in healthcare and health longevity science with Aldar’s experience in developing integrated, people-centred master-planned communities.
Although Tanzania has not reported any confirmed Ebola cases, the government continues to enhance preparedness measures through its national contingency plans.
Through this collaboration, both organisations will work to improve patient care by supporting healthcare professionals with access to the latest medical knowledge and best practices.
The CardioMEMS HF System continuously monitors pressure within the pulmonary artery, providing healthcare professionals with critical information about a patient’s cardiovascular status.
The approval expands the use of the therapy to delay the onset of Stage 3 Type 1 diabetes in children as young as one year old.